Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris H Polman

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2007
Early diagnosis of multiple sclerosis-still a challenge?Chris H Polman
Lancet (London, England)|May 18, 2004
Statins for the treatment of multiple sclerosis: cautious hopeChris H Polman, Joep Killestein
Current Opinion in Neurology|May 14, 2005
Current trials in multiple sclerosis: established evidence and future hopesJoep Killestein, Chris H Polman
Nature Reviews. Neurology|March 3, 2011
Determinants of interferon β efficacy in patients with multiple sclerosisJoep Killestein, Chris H Polman
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 30, 2003
Cannabis use in multiple sclerosis: excited interestJoep Killestein, Chris H Polman
Nederlands Tijdschrift Voor Geneeskunde|February 10, 2009
[Alemtuzumab in early multiple sclerosis]Joep Killestein, Chris H Polman
Neurology|April 28, 2010
The multiple sclerosis functional composite: a clinically meaningful measure of disabilityChris H Polman, Richard A Rudick
Neurology|April 1, 2009
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessmentRichard B Tenser, Chris H Polman
The Lancet. Neurology|May 19, 2009
Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosisRichard A Rudick, Chris H Polman
The Lancet. Neurology|August 28, 2003
New and emerging treatment options for multiple sclerosisChris H Polman, Bernard M J Uitdehaag
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2007
Early diagnosis of multiple sclerosis-still a challenge?Chris H Polman
Lancet (London, England)|May 18, 2004
Statins for the treatment of multiple sclerosis: cautious hopeChris H Polman, Joep Killestein
Current Opinion in Neurology|May 14, 2005
Current trials in multiple sclerosis: established evidence and future hopesJoep Killestein, Chris H Polman
Nature Reviews. Neurology|March 3, 2011
Determinants of interferon β efficacy in patients with multiple sclerosisJoep Killestein, Chris H Polman
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 30, 2003
Cannabis use in multiple sclerosis: excited interestJoep Killestein, Chris H Polman
Nederlands Tijdschrift Voor Geneeskunde|February 10, 2009
[Alemtuzumab in early multiple sclerosis]Joep Killestein, Chris H Polman
Neurology|April 28, 2010
The multiple sclerosis functional composite: a clinically meaningful measure of disabilityChris H Polman, Richard A Rudick
Neurology|April 1, 2009
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessmentRichard B Tenser, Chris H Polman
The Lancet. Neurology|May 19, 2009
Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosisRichard A Rudick, Chris H Polman
The Lancet. Neurology|August 28, 2003
New and emerging treatment options for multiple sclerosisChris H Polman, Bernard M J Uitdehaag
Pageof 17